Enhanced anti-cancer efficacy of hesperidin through smart polymeric nanoparticles targeting prostate cancer

dc.contributor.authorYıldırım, Metin
dc.contributor.authorAcet, Ömür
dc.contributor.authorÖnal Acet, Burcu
dc.contributor.authorKarakoç, Veyis
dc.contributor.authorOdabaşı, Mehmet
dc.date.accessioned2024-11-14T08:20:04Z
dc.date.available2024-11-14T08:20:04Z
dc.date.issued2024
dc.departmentSabire Yazıcı Fen Edebiyat Fakültesi
dc.description.abstractThe rapid progress of various nanotechnology tools is currently being utilized in the management of several fatal illnesses, including cancer. Nanopolymers that encapsulate anti-cancer medication present a highly encouraging substitute to traditional therapies, primarily because of their specific targeting and accurate functionality, making them suitable for a variety of uses. Poly(2-hydroxyethyl methacrylate) (pHEMA) is a non-toxic polymer derived from the monomer HEMA, which is known for its toxicity. It can be combined with various other polymers and is associated with minimal immune response. The objective of the current investigation is to produce smart polymeric nanoparticles that are responsive to changes in pH and temperature, and capable of encapsulating hesperidin. These hesperidin-loaded poly(2-Hydroxyethyl methacrylate-N-isopropylacrylamide-Vinyl imidazole) nanoparticles, referred to as HesSNPs, aim to enhance the bioavailability of hesperidin and augment its therapeutic effectiveness in combating prostate cancer. N-isopropylacrylamide and Vinyl imidazole were employed as monomers sensitive to temperature and pH, respectively. Nanopolymers that were synthesized underwent characterization through dynamic light scattering (DLS) analyses, scanning electron microscopy (SEM), and Fourier transform infrared spectroscopy (FTIR) to analyze particle size and charge, surface morphology, and functional group determinations, respectively. HesSNPs decreased cell viability of DU-145 cells. Flow cytometry analysis revealed that apoptosis is the main mechanism underlying cell death after HesSNPs treatment.
dc.identifier.doi10.1002/slct.202403869
dc.identifier.issn2365-6549
dc.identifier.issue36en_US
dc.identifier.scopusqualityQ3
dc.identifier.urihttps:/dx.doi.org/10.1002/slct.202403869
dc.identifier.urihttps://hdl.handle.net/20.500.12451/12638
dc.identifier.volume9en_US
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherJohn Wiley and Sons Inc
dc.relation.ispartofChemistrySelect
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/embargoedAccess
dc.subjectDU145 Cells
dc.subjectHesperidin
dc.subjectpH and Temperature Sensitive Polymer
dc.subjectProstate Cancer
dc.titleEnhanced anti-cancer efficacy of hesperidin through smart polymeric nanoparticles targeting prostate cancer
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
yildirim-metin-2024.pdf
Boyut:
1.07 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: